Pancreatic and Hepatobiliary Cancers

Cancers of the liver and pancreas remain challenging problems in oncology, with the five-year survival rates still dire for both types of cancer – 14%, overall, for all forms of liver cancer, according to a report from the American Cancer Society in 2012. The latest book in the Site-Specific Cancer Series provides an up-to-date examination of cancers of the liver, bile duct, and gallbladder and exocrine and endocrine tumors of the pancreas. Chapters in Pancreatic and Hepatobiliary Cancers explore the diagnosis, treatments options, patient management, and emerging therapies for pancreatic exocrine and endocrine tumors, gallbladder cancer and bile duct tumors, primary hepatocellular carcinoma, and liver metastases. In addition, chapters also provide you with information on quality of life and symptom management, nutritional challenges for patients with these types of cancers as well as nutrition symptoms and management strategies, advance care planning, and the economic and social challenges faced by patients with pancreatic and hepatobiliary cancers. Liver and pancreatic cancers are difficult diseases of the gastrointestinal tract and are often met with poor outcomes. Caring for patients with these types of cancers can also be challenging – with complex treatment plans, complicated side effect management, and difficult nutrition management – and this new book provides you with the information and details you’ll need to properly care for an at-risk patient population.